Date published: 2026-3-3

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olr490 Inhibitors

Olr490 inhibitors represent a class of chemical compounds that interact specifically with the olfactory receptor 490 (Olr490), a G protein-coupled receptor (GPCR) predominantly involved in olfactory signaling pathways. These inhibitors are characterized by their ability to modulate the receptor's activity, often by binding to specific sites on the receptor and altering its conformation. The molecular structure of Olr490 inhibitors is typically designed to fit the binding pocket of the Olr490 receptor with high specificity, ensuring effective interaction at the molecular level. This interaction can lead to the inhibition of the receptor's natural function, which in the context of olfactory receptors, involves the recognition and transduction of specific odorant molecules. The inhibition process often results from either competitive or allosteric modulation, where the inhibitor either directly competes with the natural ligand for the binding site or induces a conformational change in the receptor, reducing its ability to interact with the ligand.

The study and design of Olr490 inhibitors involve understanding the receptor's structure, including its active sites, and the dynamics of receptor-ligand interactions. Researchers utilize various computational and experimental approaches, such as molecular docking and structure-activity relationship (SAR) studies, to identify and optimize compounds that effectively inhibit Olr490. These inhibitors are also important tools in studying the fundamental biology of olfactory receptors and their roles in chemosensory systems. By blocking the function of Olr490, scientists can dissect the receptor's contributions to olfactory signaling and explore the broader implications of receptor inhibition on related biochemical pathways. The development and characterization of these inhibitors provide insights into receptor-ligand interactions at a molecular level, contributing to the broader field of receptor biology and chemical signaling.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

AICAR

2627-69-2sc-200659
sc-200659A
sc-200659B
50 mg
250 mg
1 g
$65.00
$280.00
$400.00
48
(2)

Activates AMPK, which can influence metabolic pathways and potentially proteins associated with them.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

A MEK inhibitor, affecting the MAPK/ERK pathway and potentially proteins involved in this signaling cascade.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

Inhibits PI3K, altering the AKT signaling pathway, which may affect proteins downstream of this pathway.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

An mTOR inhibitor, which can influence proteins involved in cell growth and proliferation pathways.

SB 431542

301836-41-9sc-204265
sc-204265A
sc-204265B
1 mg
10 mg
25 mg
$82.00
$216.00
$416.00
48
(1)

Inhibits the TGF-β pathway, potentially affecting proteins involved in this signaling process.

KN-93

139298-40-1sc-202199
1 mg
$182.00
25
(1)

Inhibits CaMKII, potentially affecting proteins associated with calcium signaling.

Ivermectin

70288-86-7sc-203609
sc-203609A
100 mg
1 g
$57.00
$77.00
2
(2)

Modulates ion channels, potentially influencing proteins involved in neuronal signaling pathways.

IWP-2

686770-61-6sc-252928
sc-252928A
5 mg
25 mg
$96.00
$292.00
27
(1)

Inhibits Wnt processing and secretion, potentially affecting proteins in the Wnt signaling pathway.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$186.00
$707.00
88
(1)

ROCK inhibitor, potentially affecting proteins involved in cytoskeleton organization and cell motility.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

Inhibits MEK, potentially influencing proteins in the MAPK/ERK pathway.